JS

James Steele

Director Director DIN 09155919
DIN 09155919 First appointment Apr 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About James Steele

Data last updated:

James Steele was a Director at Aceto Pharma (India) Private Limited (2021–2025) and Director at Finar Limited (from 2021). The companies operate in Pharma.

DIN 09155919
Primary Designation Director
Industry Pharma
First Appointment 26 Apr 2021
Oldest Company Age 28 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aceto Pharma (India) Private Limited U24232GJ2007FTC142338
Director26 Apr 20212007₹341 Cr (FY 2025)Active
Finar Limited U24231GJ1998PLC034615
Director13 May 20211998₹331 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Finar Limited
Aceto Pharma (India) Private Limited
Premium access

Shareholding and investment profile for James Steele

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about James Steele

James Steele was first appointed on 26 Apr 2021 as Director at Aceto Pharma (India) Private Limited.

James Steele held 2 earlier board appointments: Aceto Pharma (India) Private Limited (Director, 26 Apr 2021 to 25 Jun 2025); Finar Limited (Director, from 13 May 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available